Review on Novel Monoamine Oxidase Inhibitors: A Clinician’s Guide

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2021, Vol 5, Issue 2

Abstract

The purpose of this review is to provide information on the mechanisms of action, pharmacokinetics, therapeutic effectiveness, safety, and tolerability of four novel antidepressants: pirlindole, safinamide, selegiline, and toloxatone. In spite of the initial pharmacological interest, monoamine oxidase (MAO) inhibitors are used in clinics for their antidepressant effects and in the treatment of Parkinson’s syndrome due to proven neuroprotective effects. Patients with a lack of efficacy or tolerability for some monoamine oxidase inhibitors may benefit from the option of a new one monoamine oxidase inhibitors with various mechanism of actions. In the selection of newer monoamine oxidase inhibitors, these drugs may be an alternative. The simple deficiency of serotonin in the brain does not cause depression, but rather a complex interplay of different neurotransmitters, including some regions of the brain include serotonin, norepinephrine, dopamine and histamine. The novel monoamine oxidase inhibitors described above exert their therapeutic advantages by acting on multiple neurotransmitters. When formulating a plan of treatment, the ambiguity of the underlying neurobiological process should be considered.

Authors and Affiliations

Patil AJ and Suryawanshi MR*

Keywords

Related Articles

The Utilization of Residue Come Out as a By-Product by the Cold Press

In recent years, with the increase of the world population, the studies on the utilization of the herbal wastes resulting from increased industrialization and production have gained speed and importance. Vegetable oils t...

Cloud Computing and Biological Data

The diversity of data leads to volume, velocity, variety, variability and value, the “V”s of big data worldwide known. And these are the challenges for biomedical and data scientists to bring proper information out of th...

Benzimidazole:- A Versatile Moiety

Benzimidazole is a promising nitrogen-containing nucleus with extensive pharmacological activity, some of which are listed in this article, such as antiprotozoal, anthelmintic, antipsychotic, antiparasitic, antifungal,...

Drug Therapy Problems among Patients with both Cardiovascular Diseases and Diabetes Mellitus in a Sub-Saharan African Referral Hospital

Background: Patients with both type 2 diabetes mellitus and cardiovascular disease receive multiple medications but there are limited studies on drug therapy problems among them in Sub-Saharan Africa. Objective: To det...

Phytochemical Screening of Some Spices Used as Condiment in Kano, North western Nigeria

Spices have been added to foods since ancient times, not only as flavouring agent, but also as food preservatives and folk medicines. The study was aimed to screened for qualitative and quantitative bioactive constituent...

Download PDF file
  • EP ID EP748568
  • DOI 10.23880/oajpr-16000240
  • Views 33
  • Downloads 0

How To Cite

Patil AJ and Suryawanshi MR* (2021). Review on Novel Monoamine Oxidase Inhibitors: A Clinician’s Guide. Open Access Journal of Pharmaceutical Research, 5(2), -. https://europub.co.uk/articles/-A-748568